Microsoft and Meta's strong earnings reports that eased investor fears of an economic slowdown amid President Trump's tariffs ...

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

Researchers in Dallas want to know if the class of drugs, GIP/GLP-1 receptor agonists, might be a secret weapon in the fight ...